Gefitinib-induced rash and nephrotic syndrome
Article in Adverse Drug Reactions Journal (November 2023)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
EGFR is a potential dual molecular target for cancer and Alzheimer’s disease
Article in Frontiers in Pharmacology (August 2023)
A Review of the Evolving Landscape of Inclusive Research and Improved Clinical Trial Access
Article in Clinical Pharmacology & Therapeutics (January 2023)